Trial Information
Endobronchial Ultrasound Guided Transbronchial Needle Aspiration for the Mediastinal Re-Staging After Induction Therapy in Non-Small Cell Lung Cancer. A Prospective Study
Inclusion Criteria:
- Histologically proven non-small cell lung cancer
- Patients who have initially histologically proven N2 disease (Stage IIIA)
- Patients who underwent induction treatment (chemotherapy or chemoradiation therapy)
and are considred for surgery
- Written informed consent
Exclusion Criteria:
- Contraindications for bronchoscopy
- Medically inoperable patients
- Patients who are found to have M1 disease, inoperable T4 disease or supraclavicular
metastasis after induction treatment
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
The diagnostic values of EBUS-TBNA in the mediastinal re-staging after induction treatment in non-small cell lung cancer.
Outcome Time Frame:
1.5 years
Safety Issue:
No
Principal Investigator
Bin Hwangbo, MD. PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Goyang, Gyeonggi-do, Korea, Republic of
Authority:
South Korea: Korea Food and Drug Administration (KFDA)
Study ID:
NCCTS-06-211
NCT ID:
NCT00859742
Start Date:
March 2009
Completion Date:
August 2010
Related Keywords:
- Non Small Cell Lung Cancer
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms